Comparison of the Epifaith® Syringe With the Plastic Syringe

Sponsor
Chang Gung Memorial Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06085027
Collaborator
(none)
300
2
12

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the efficiency of identifying epidural space with either the Epifaith® syringe or the plastic syringe in parturients. The main questions it aims to answer are:

  • Whether it consume less time identifying epidural space with the Epifaith® syringe

  • Whether the usage of the Epifaith® syringe decrease the complication rate and failure of labor analgesia Participants will receive labor analgesia either with the Epifaith® syringe or the plastic syringe conducted by experienced resident doctors.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Labor analgesia
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Compare the Epifaith® Syringe With the Plastic Syringe for Identification of the Epidural Space in Parturients: A Prospective Randomized Control Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: The Epifaith® syringe

Procedure: Labor analgesia
Perform epidrual analgesia for parturients between 18 to 45 year-old

Active Comparator: The plastic syringe

Procedure: Labor analgesia
Perform epidrual analgesia for parturients between 18 to 45 year-old

Outcome Measures

Primary Outcome Measures

  1. Time consumed to identify the epidural space [During the procedure]

    Starting on the moment which the syringe be attached to the needle

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA II to III

  • Require labor analgesia

  • Has submitted inform consent

Exclusion Criteria:
  • ASA IV or above

  • Coagulopathy

  • Spinal deformity

  • Neurological, psychological, cardiopulmonary disorder

  • Active liver or kidney injury

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Chang Gung Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT06085027
Other Study ID Numbers:
  • 202301331A3
First Posted:
Oct 16, 2023
Last Update Posted:
Oct 16, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 16, 2023